Last updated: July 10, 2026

Application No. 19/388,923

Untitled Application

Unknown

Filed

1600

Priority

Jan 22, 2018 — CN 201810060265.9 +2 more

Examiner

DICKINSON, PAUL W

Art Unit

1618

Tech Center

Beijing Inno Medicine Co., Ltd.

Assignee

Beijing Inno Medicine Co. Ltd.

OA Round

1 (Non-Final)

Interview Optional

— +9.6% interview lift. Interview lift (+9.6%) is below the 15.0% threshold. A written response is recommended.

Based on 1036 resolved cases, 2023–2026

Examiner Intelligence

DICKINSON, PAUL W View full profile →

Grants 63% of resolved cases

Career Allowance Rate

652 granted / 1036 resolved

+2.9% vs TC avg

Moderate +10% lift

Without

With

+9.6%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

42 currently pending

Career history

1076

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

62.2%

+22.2% vs TC avg

§102

11.5%

-28.5% vs TC avg

§112

6.4%

-33.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1036 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/297,924

Patent 12673926

NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING

5y 1m to grant Granted Jul 07, 2026

18/296,642

Patent 12649001

COMPLEXES FOR DELIVERY OF ANTIGENIC PEPTIDES

3y 2m to grant Granted Jun 09, 2026

16/489,221

Patent 12642867

CONJUGATES COMPRISING OCULAR ANGIOGENESIS GROWTH FACTOR APTAMERS AND USES THEREOF IN THE DETECTION AND TREATMENT OF OPHTHALMOLOGICAL ANGIOGENESIS INDICATIONS

6y 9m to grant Granted Jun 02, 2026

16/961,349

Patent 12642875

LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF

5y 10m to grant Granted Jun 02, 2026

17/608,911

Patent 12636384

NANOEMULSION WITH PORPHYRIN SHELL

4y 6m to grant Granted May 26, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

63%

Grant Probability

72%

With Interview (+9.6%)

3y 3m

Median Time to Grant

Low

PTA Risk

Based on 1036 resolved cases by this examiner. Grant probability derived from career allowance rate.